Patient Diagnosed With Clinical Stage T1c Prostate Cancer
After receiving a PSA screening exam, a 65-year-old man is diagnosed with clinical stage T1c prostate cancer. What imaging study is most appropriate to complete his workup?
A 65-year-old man is diagnosed with prostate cancer after receiving a prostate-specific antigen (PSA) screening exam. His initial PSA level is 8.5 ng/mL; 3 out of 12 biopsy cores are involved with Gleason score 3 + 3 = 6 prostate cancer. On exam his prostate is non-enlarged and there is no palpable nodularity (clinical stage T1c).
What imaging study is most appropriate to complete his workup?
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
